Research and development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) mission needs and Small Business Innovation Research (SBIR) program objectives
ID: 75N91024R00006Type: BOTH
Overview

Topic

Research and development (R&D) that will contribute toward Advanced Research Projects Agency for Health (ARPA-H) mission needs and Small Business Innovation Research (SBIR) program objectives

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: SBIRPhase: BOTHYear: 2024

Topic Link

https://www.sbir.gov/node/2516987

Additional Information

https://sam.gov/opp/a738f57f6f884dd49f3135c97b037d95/view
Timeline
  1. 1
    Release Jan 23, 2024 12:00 AM
  2. 2
    Open Jan 23, 2024 12:00 AM
  3. 3
    Next Submission Due Feb 22, 2024 12:00 AM
  4. 4
    Close Feb 22, 2024 12:00 AM
Description

The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for research and development (R&D) projects that align with the mission needs of the Advanced Research Projects Agency for Health (ARPA-H) and the objectives of the Small Business Innovation Research (SBIR) program. The solicitation invites proposals in various areas, including inexpensive plant-based manufacturing of viral vectors for gene therapies, continuous monitoring of vascular health using smart biomimetic implantables, and personalized medicine platforms for predicting response to immunotherapy, among others. The deadline for questions is February 15, 2024, and proposals must be received by February 22, 2024. For more information, please refer to the solicitation agency URL: [link].

Files
No associated files provided.
Similar Opportunities
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the late-stage translation of biomedical and behavioral research results in arthritis and musculoskeletal and skin diseases from academic/non-profit labs to the marketplace. This Small Business Innovation Research (SBIR) grant opportunity aims to support the development of diagnostic tools, prevention tools, and treatments for these diseases. The focus is on moving lab technologies towards commercial dissemination through partnerships and close collaboration between small businesses and the original developers of the technologies. The research objectives include late-stage pre-clinical studies on technology or therapy feasibility, as well as studies required for regulatory approval before clinical testing. Clinical trials are excluded from this opportunity. The research topics of interest include the development of therapies, innovative drug delivery strategies, biomarker studies, outcome measures and methodologies, and 3D human tissue models. Collaboration between academic/non-profit labs and small businesses is encouraged, with the academic/non-profit labs performing a portion of the project. The proposal should include milestones with quantitative success criteria to measure the progress and efficacy of the project. Applications that do not originate from academic/non-profit labs or propose intervention studies are not responsive to this opportunity. The grant is open for applications until September 6, 2025. For more information, visit the solicitation agency URL: [link](https://grants.nih.gov/grants/guide/PA-files/PAR-23-032.html).
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Innovation Research (SBIR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and tools for monitoring cognitive function. The solicitation is open until September 8, 2025, with multiple application due dates throughout the year. More information can be found on the grants.gov website.
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of novel tools and devices for animal research facilities and to support the care of animal models. The Office of Research Infrastructure Programs (ORIP) is encouraging applications from small business concerns (SBCs) for Small Business Innovation Research (SBIR) projects in this area. The goal of this solicitation is to improve animal welfare, ease the management of individual animals and animal colonies, and enhance the monitoring and control of environmental conditions that affect outcomes and reproducibility in animal model research. The variation of extrinsic factors between different animal facilities has been cited as a source of irreproducibility in animal research, and this solicitation aims to address this issue. The solicitation highlights the need for devices that can accurately monitor challenging environmental conditions such as humidity, vibrations, odors, and ultrasonic noise. Additionally, there is a need for devices that can identify various pathogens, allergens, and pollutants in environments supporting laboratory animals. Noninvasive or minimally invasive bio-logging devices for real-time monitoring of animal behavior, food/water consumption, and bodily functions are also desired. Other areas of focus include the development of tools to ease the handling and restraining of animals, as well as the connection of diet, environmental conditions, and physiological measurements to understand the effects of extrinsic factors on experimental outcomes. The solicitation emphasizes the importance of innovation and the potential for adapting technologies from one field to another. The solicitation is open for applications, with multiple due dates throughout the year. Funding specifics and project duration can be found in the solicitation document available at the provided links. Applicants are advised to discuss their projects with the Scientific/Research contacts before submitting an application.
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) through their Small Business Innovation Research (SBIR) program. The goal of this funding opportunity is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and tools for monitoring cognitive function. The solicitation is open until September 8, 2025, with multiple application due dates throughout the year. More information can be found on the grants.gov and NIH websites.
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Active
Department of Health and Human Services
The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for advancing research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). The goal of this solicitation is to encourage research and commercialization of novel therapies, devices, products, and healthcare programs to prevent the onset of AD/ADRD and reduce the burden on individuals, families, and society. The research areas of interest include prevention, diagnosis, treatment, care, tools, and technology. Examples of specific topics include behavioral interventions, diagnostic screening tests, drug development, in-home technologies, and educational training programs. The solicitation is open for applications until September 6, 2025, and the funding will be provided through the Small Business Technology Transfer (STTR) program. For more information and to submit a proposal, visit the grants.gov website or the National Institutes of Health's solicitation page.